Model
Edge
Lyell Immunopharma Inc.
LYEL
Filing type
3
Filing date
Sep 9, 2026
Updated
Sep 10, 2026 ยท 5:30 PM
Copy reference
Filing
3
Initial Statement of Beneficial Ownership